Dashboard
Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 4.17%
- Poor long term growth as Net Sales has grown by an annual rate of 8.85% over the last 5 years
- Low ability to service debt as the company has a high Debt to EBITDA ratio of 4.89 times
Negative results in Sep 26
With ROCE of 3.5, it has a Very Expensive valuation with a 18.3 Enterprise value to Capital Employed
Despite the size of the company, domestic mutual funds hold only 0.31% of the company
Stock DNA
Specialty Chemicals
INR 1,768 Cr (Micro Cap)
745.00
15
0.00%
0.41
3.41%
26.11
Total Returns (Price + Dividend) 
Indokem for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News

Indokem Ltd Technical Momentum Shifts Amid Mixed Indicator Signals
Indokem Ltd, a micro-cap player in the Specialty Chemicals sector, has exhibited a notable shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. Despite this positive directional change, key technical indicators present a nuanced picture, with some suggesting caution amid mixed signals. This article analyses the recent price action, momentum indicators, and moving averages to provide a comprehensive view of Indokem’s current market positioning.
Read More
Indokem Ltd Faces Technical Momentum Shift Amid Mixed Market Signals
Indokem Ltd, a micro-cap player in the Specialty Chemicals sector, has experienced a notable shift in its technical momentum, reflecting a complex interplay of bearish and bullish signals across key indicators. Despite a recent downgrade to a Strong Sell rating by MarketsMojo, the stock’s price action and technical parameters suggest a sideways trend, challenging investors to carefully analyse the evolving market dynamics.
Read More
Indokem Ltd is Rated Strong Sell
Indokem Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 03 Nov 2026. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 14 November 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read More Announcements 
Announcement under Regulation 30 (LODR)-Newspaper Publication
03-Nov-2026 | Source : BSEPursuant to Regulation 47 of SEBI (LODR) Regulations 2015 we enclose herewith copies of newspaper advertisements regarding extract of unaudited financial results for the quarter and half year ended 30th September 2026 as approved in the meeting of board of directors held on 2nd November 2026 and opening of Special Window for re-lodgement of transfer of physical shares.
Financial Results For The Quarter And Half Year Ended 30Th September 2026.
02-Nov-2026 | Source : BSEThe unaudited Standalone and Consolidated Financial Results for the quarter and half year ended 30th September 2026 were approved by the Board of Directors at its meeting held today.
Board Meeting Outcome for Board Meeting Outcome For Meeting Held On 02Nd November 2026
02-Nov-2026 | Source : BSEPursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 (Listing Regulations) we hereby inform you that the Board of Directors at its Meeting held today has approved the matter as mentioned in the enclosed intimation.
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Sep 2026
Shareholding Compare (%holding) 
Promoters
None
Held by 10 Schemes (0.1%)
Held by 0 FIIs
Vindhyapriya Holdings Pvt Ltd (19.76%)
Sangeetha S (1.79%)
25.46%
Quarterly Results Snapshot (Consolidated) - Sep'26 - YoY
YoY Growth in quarter ended Sep 2026 is 17.25% vs -6.91% in Sep 2025
YoY Growth in quarter ended Sep 2026 is 4.88% vs 0.00% in Sep 2025
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is 1.99% vs -5.01% in Sep 2024
Growth in half year ended Sep 2025 is 180.43% vs 72.67% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'25
YoY Growth in nine months ended Dec 2025 is 0.18% vs -0.87% in Dec 2024
YoY Growth in nine months ended Dec 2025 is 337.50% vs 87.67% in Dec 2024
Annual Results Snapshot (Consolidated) - Mar'26
YoY Growth in year ended Mar 2026 is -4.89% vs 8.06% in Mar 2025
YoY Growth in year ended Mar 2026 is -41.01% vs 151.21% in Mar 2025